Gene Solutions Secures Patent for Platform Technology Targeting Mitochondrial Dysfunction in Neurological Diseases

Gene Solutions, a leader in mitochondrial dysfunction genomics and CNS drug discovery, announces the publication of its platform technology patent. The a...

September 12, 2025 | Friday | News
uLab Systems and Biolux Technology Forge Strategic Partnership to Redefine Clear Aligner Therapy

uLab Systems®, a leader in digital orthodontic innovation, and Biolux Technology, creator of the OrthoPulse® near-infrared (NIR) light therapy de...

September 12, 2025 | Friday | News
Olympus Launches iTind™ Center of Excellence Program to Advance Care for Men with Enlarged Prostate

Olympus Corp. of the Americas is proud to announce the new iTind™ Center of Excellence (COE) Program, which is designed to enhance care, experience...

September 12, 2025 | Friday | News
Scipher Medicine and Maxymune Therapeutics Partner to Advance AI-Driven Target Discovery in Immunology

Scipher Medicine, a pioneer in network-based and AI-driven precision immunology,  announced a strategic collaboration with Maxymune Therapeutics, a ...

September 11, 2025 | Thursday | News
Greenwich LifeSciences Secures FDA Fast Track Designation for GLSI-100 in Breast Cancer

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-0...

September 11, 2025 | Thursday | News
Booking Health Expands Access to Dendritic Cell Immunotherapy for Recurrent Glioblastoma as New Clinical Data Confirm Survival Gains

Booking Health, a global medical travel platform, announced the expansion of patient access to dendritic cell immunotherapy for recurrent glioblastoma, f...

September 10, 2025 | Wednesday | News
Cellworks myCare-040 Study Demonstrates Predictive Power of Computational Modeling to Guide Chemo-Immunotherapy Decisions in Advanced NSCLC

-Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Best-in-Class PTRS, announced results from the landmark myCare-040 clinical ...

September 09, 2025 | Tuesday | News
Corner Therapeutics Unveils Breakthrough Hyperactivator Technology Showing Potential for a Universal Influenza Vaccine and Cancer Immunotherapy

Corner Therapeutics, an in vivo T cell modulation and immunotherapy company pioneering novel approaches to cancer and infection, published research in mB...

September 09, 2025 | Tuesday | Reports
InnoCare Pharma Wins Singapore HSA Approval for HIBRUKA Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA ...

September 09, 2025 | Tuesday | News
Johnson & Johnson Expands ACUVUE® Portfolio with Breakthrough Toric Lenses in Europe and Middle East

World’s #1 Selling Contact Lens Brand ACUVUE® brings pioneering innovation for astigmatic patients, providing visual clarity and comfort Johns...

September 08, 2025 | Monday | News
Daiichi Sankyo and Merck Report Positive Phase 2 Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 2...

September 08, 2025 | Monday | News
Science 37 and Catalent Partner to Transform Clinical Trial Access with Direct-to-Patient IMP Delivery

Science 37, the leader in expanding patient access to clinical trials, and Catalent®, a global leader in enabling pharma, biotech, and consumer healt...

September 05, 2025 | Friday | News
Andelyn Biosciences Partners with Tern Therapeutics to Advance Late-Stage Manufacturing of Gene Therapy for CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...

September 05, 2025 | Friday | News
Gilead Breaks Ground on $32 Billion U.S. Innovation Commitment with New Technical Development Center in Foster City

Gilead Sciences celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the co...

September 04, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close